The results showed that most of previously mentioned compounds could alleviate brain damage caused by cerebral ischemia/reperfusion via inhibiting the expression of TLR2, TLR4, and inflammatory cytokines NF-κB, iNOS, COX-2, IL-6, and TNF-α [55, 61, 62]. This evidence concerns the gene TLR4 and brain ischemia.